Lineage Cell Therapeutics (LCTX) EBT Margin Growth (1y) (2011 - 2026)
Lineage Cell Therapeutics (LCTX) EBT Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,526.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 452.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Lineage Cell Therapeutics | 267.08 Mn | 203.18 Mn | 1.73 Mn | -66,713.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -66,713.00 |
| Dec 31, 2025 | 2,523.00 |
| Sep 30, 2025 | -43,260.00 |
| Jun 30, 2025 | -40,499.00 |
| Mar 31, 2025 | 76.00 |
| Dec 31, 2024 | 11,245.00 |
| Sep 30, 2024 | 49,507.00 |
| Jun 30, 2024 | -24,868.00 |
| Mar 31, 2024 | -19,401.00 |
| Dec 31, 2023 | 10,645.00 |
| Sep 30, 2023 | -38,852.00 |
| Jun 30, 2023 | -1,238.00 |
| Mar 31, 2023 | -12,470.00 |
| Dec 31, 2022 | -27,620.00 |
| Sep 30, 2022 | 20,373.00 |
| Jun 30, 2022 | 82,077.00 |
| Mar 31, 2022 | 23,489.00 |
| Dec 31, 2021 | -33,320.00 |
| Sep 30, 2021 | 100,260.00 |
| Jun 30, 2021 | 72,198.00 |